Paris, 8 December 2025 ROCHE BOBOIS SA (ISIN: FR0013344173 - Ticker symbol: RBO), high-end furniture global market leader and the name behind French Art de Vivre, announces its provisional calendar ...

If you’re remodeling or building a home, Murphy recommends adding a spot for a child to sit, read or relax. “I often ...

How Reka Design Week 2025, Malaysia’s design showcase, revived appreciation for craftsmanship and materiality.

Roche Bobois, the iconic Spanish filmmaker, and his muse Rossy de Palma come together in the Cromática collection — ...

Levi Garraway, Roche's chief medical officer and head of global product development. Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 ...

Roche Holding's fair value estimate has seen a modest increase, with the latest target rising from CHF 298.64 to CHF 304.50. This change follows analyst updates that reflect a balance of positive ...

Roche shares rose after the Swiss pharmaceutical company said an experimental pill for breast cancer showed positive results in a large late-stage trial. The drugmaker said Tuesday that the trial ...

FRANKFURT, Nov 18 (Reuters) - Roche's <ROG.S, opens new tab experimental oral drug giredestrant has been shown to cut the risk of recurrence of a common form of breast cancer after surgery, boosting ...

Roche has reported another phase 3 win for its oral selective estrogen receptor degrader (SERD). Success at a planned interim analysis positions giredestrant for use in the adjuvant setting, setting ...

Credit: David Singer David Singer, of Brooks World Travel, was on WATD last week seeking volunteers to help them unload Christmas Trees for their annual fundraiser and so far the response has been ...

Roche has reported wins for its BTK inhibitor fenebrutinib in a pair of phase 3 studies across two multiple sclerosis (MS) populations. One victory was based on the finding that the candidate was ...